CBS 2019
CBSMD教育中心
English

科学研究

科研文章

荐读文献

Right ventricular expression of NT-proBNP adds predictive value to REVEAL score in patients with pulmonary arterial hypertension Atrial Fibrillation: JACC Council Perspectives Long-term efficacy and safety of drug-coated balloons versus drug-eluting stents for small coronary artery disease (BASKET-SMALL 2): 3-year follow-up of a randomised, non-inferiority trial Percutaneous Pulmonary Angioplasty for Patients With Takayasu Arteritis and Pulmonary Hypertension Percutaneous coronary interventional strategies for treatment of in-stent restenosis: a network meta-analysis Percutaneous coronary intervention with drug-coated balloon-only strategy in stable coronary artery disease and in acute coronary syndromes: An all-comers registry study Outcomes with drug-coated balloons in small-vessel coronary artery disease Orbital atherectomy for treating de novo, severely calcified coronary lesions: 3-year results of the pivotal ORBIT II trial Treatment of Drug-Eluting Stent In-Stent Restenosis With Drug-Eluting Balloons: A Systematic Review and Meta-Analysis Treating Bifurcation Lesions: The Result Overcomes the Technique
|<<... 160 161 162 163 164 165 166 ...>>|

Original Research2021 May 6. doi: 10.1002/ehf2.13410.

JOURNAL：ESC Heart Fail. Article Link

Right ventricular expression of NT-proBNP adds predictive value to REVEAL score in patients with pulmonary arterial hypertension

WT Chang, JY Shih, ChS Hong et al. Keywords: Group I PAH; HF hospitalization; NT-proBNP; RV expression.

Full Text PDF

>CBS CBS 2019

> CBS 2019

> CBS 2019 注册

> CBS 2019 会议日程

> CBS 2019 学术征集

> CBS 2019 热点

 CBSMD

> CBSMD 网站注册

> 教育中心

> 荐读文献

> Top 10 阅读文献

> 文献导读
CBS 2019 CBS 2019 主席团 教育中心 科研动态
Copyright ⓒ CBS MD Nanjing China. All rights reserved. 京ICP备16025898号-11
联系我们| Top